{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:29:47Z","timestamp":1771014587910,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.expneurol.2006.04.015","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T09:31:49Z","timestamp":1150018309000},"page":"172-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions"],"prefix":"10.1016","volume":"201","author":[{"given":"Muriel B.","family":"S\u00e4ttler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Gadjanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.04.015_bib1","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.4049\/jimmunol.173.9.5794","article-title":"Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis","volume":"173","author":"Aktas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0896-6273(88)90127-4","article-title":"Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning","volume":"1","author":"Barres","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2006.04.015_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archneur.62.4.563","article-title":"Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis","volume":"62","author":"Biernacki","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1212\/01.WNL.0000055926.69643.03","article-title":"Evidence of early cortical atrophy in MS: relevance to white matter changes and disability","volume":"60","author":"De Stefano","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib5","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1523\/JNEUROSCI.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway","volume":"23","author":"Diem","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.04.015_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2006.04.015_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(02)00098-X","article-title":"Interferon-beta directly influences monocyte infiltration into the central nervous system","volume":"127","author":"Floris","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/01.WNL.0000113765.75855.19","article-title":"Interferon-beta-1b slows progression of atrophy in RRMS: three-year follow-up in NAb\u2212 and NAb+ patients","volume":"62","author":"Frank","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-0102(03)00217-7","article-title":"Axonal damage is reduced following glatiramer acetate treatment in C57\/bl mice with chronic-induced experimental autoimmune encephalomyelitis","volume":"47","author":"Gilgun-Sherki","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2006.04.015_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/01.WNL.0000149516.30155.B8","article-title":"Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a","volume":"64","author":"Hardmeier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.1111","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"36","author":"Iglesias","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2006.04.015_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/exnr.1999.7094","article-title":"Long-term effect of inhibition of ced 3-like caspases on the survival of axotomized retinal ganglion cells in vivo","volume":"158","author":"Kermer","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib15","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","article-title":"T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies","volume":"97","author":"Kipnis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2006.04.015_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib17","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.56.11.1505","article-title":"Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results","volume":"56","author":"Li","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib18","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.182.5.1517","article-title":"Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma","volume":"182","author":"Lu","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2006.04.015_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2004.tb00081.x","article-title":"Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats","volume":"14","author":"Maier","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib20","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.04.015_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/brain\/awf177","article-title":"Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance","volume":"125","author":"Miller","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2006.04.015_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.expneurol.2006.04.015_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s004150170052","article-title":"Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b","volume":"248","author":"Narayanan","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00415-003-0965-8","article-title":"Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis","volume":"250","author":"Parry","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib26","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.04.015_bib27","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.53.8.1698","article-title":"Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group","volume":"53","author":"Rudick","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib28","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.4049\/jimmunol.157.12.5721","article-title":"The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats","volume":"157","author":"Ruuls","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.64.2.204","article-title":"1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study","volume":"64","author":"Sarchielli","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2006.04.015_bib30","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2006.04.015_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.expneurol.2004.12.010","article-title":"Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis","volume":"193","author":"S\u00e4ttler","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jnr.1128","article-title":"Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration","volume":"65","author":"Schmidt","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2006.04.015_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00386254","article-title":"Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein","volume":"87","author":"Sherriff","year":"1994","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.expneurol.2006.04.015_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/71548","article-title":"Autoimmune encephalomyelitis ameliorated by AMPA antagonists","volume":"6","author":"Smith","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2006.04.015_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-5728(95)00059-B","article-title":"Interferon-beta down regulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes","volume":"60","author":"Soilu-Hanninen","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.56.11.1496","article-title":"Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.04.015_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.163.1.40","article-title":"Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the \u201cresistant\u201d Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response","volume":"163","author":"Stefferl","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.410370511","article-title":"The effect of interferon-beta on blood\u2013brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis","volume":"37","author":"Stone","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib39","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1167\/iovs.02-1136","article-title":"Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma","volume":"44","author":"Tezel","year":"2003","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.expneurol.2006.04.015_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.04.015_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-5728(97)00207-5","volume":"84","author":"van der Meide","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI3022","article-title":"MHC haplotype-dependent regulation of MOG-induced EAE in rats","volume":"102","author":"Weissert","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2006.04.015_bib43","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/ana.410360714","article-title":"Animal models","volume":"36","author":"Wekerle","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/08820139909061141","article-title":"Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion","volume":"28","author":"Yasuda","year":"1999","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.expneurol.2006.04.015_bib45","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.167.3.1171","article-title":"Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta","volume":"167","author":"Yoshida","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2006.04.015_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-5728(95)00160-3","article-title":"Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis","volume":"64","author":"Yu","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2006.04.015_bib47","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy, brain-derived neurotrophic factor","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:42:31Z","timestamp":1762148551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606002512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0014488606002512"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.04.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}